Ontology type: schema:ScholarlyArticle
2019-02-21
AUTHORSAnna Buigues, Maria Marchante, Sonia Herraiz, Antonio Pellicer
ABSTRACTDiminished ovarian reserve (DOR) and primary ovarian insufficiency (POI) are primary factors leading to infertility. However, there is a lack of appropriate animal models of DOR usable for assessing new therapeutic strategies. In this study, we aimed to evaluate whether chemotherapy treatment in mice could reproduce features similar of that observed in women with DOR. Twenty-one Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) female mice were allocated to 3 groups (n = 7/group): control, single dose of vehicle (Dimethyl Sulfoxide [DMSO]); DOR, single reduced chemotherapy dose; and POI, single standard chemotherapy dose. After 21 days, mice underwent ovarian hyperstimulation and mating. Part of the animals were harvested to analyze ovarian reserve, ovulation and fertilization rates, and morphology, apoptosis, and vascularization of the ovarian stroma. The remaining mice underwent multiple matings to assess pregnancy rates and litter sizes. The DOR and POI mice showed an impaired estrous cyclicity and a decrease in ovarian mass, number of follicles, Metaphase II (MII) oocytes, and embryos as well as in ovarian stroma vascularization. Mice in both models showed also an increase in the percentage of morphologically abnormal follicles, stromal degeneration, and apoptosis. Similar to that observed in DOR and POI patients, these impairments were less severe in DOR than in POI mice. None of the POI females were able to achieve a pregnancy. Meanwhile, DOR females achieved several consecutive pregnancies, although litter size was decreased when compared to controls. In conclusion, a mouse model which displayed most of the ovarian characteristics and fertility outcomes of women with DOR has been established using a single dose of chemotherapy. More... »
PAGES1933719119831784
http://scigraph.springernature.com/pub.10.1177/1933719119831784
DOIhttp://dx.doi.org/10.1177/1933719119831784
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1112291919
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/30791852
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1114",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Paediatrics and Reproductive Medicine",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "2 Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, Valencia University, Valencia, Spain.",
"id": "http://www.grid.ac/institutes/grid.5338.d",
"name": [
"1 IVI Foundation, Valencia Spain.",
"2 Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, Valencia University, Valencia, Spain."
],
"type": "Organization"
},
"familyName": "Buigues",
"givenName": "Anna",
"id": "sg:person.011724070757.34",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011724070757.34"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "2 Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, Valencia University, Valencia, Spain.",
"id": "http://www.grid.ac/institutes/grid.5338.d",
"name": [
"1 IVI Foundation, Valencia Spain.",
"2 Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, Valencia University, Valencia, Spain."
],
"type": "Organization"
},
"familyName": "Marchante",
"givenName": "Maria",
"id": "sg:person.010363147373.02",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010363147373.02"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "4 IVI-RMA Valencia, Valencia, Spain.",
"id": "http://www.grid.ac/institutes/grid.419275.c",
"name": [
"1 IVI Foundation, Valencia Spain.",
"3 Reproductive Medicine Research Group, IIS La Fe, Valencia, Spain.",
"4 IVI-RMA Valencia, Valencia, Spain."
],
"type": "Organization"
},
"familyName": "Herraiz",
"givenName": "Sonia",
"id": "sg:person.0725244145.42",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725244145.42"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "5 IVI-RMA Rome, Rome, Italy.",
"id": "http://www.grid.ac/institutes/None",
"name": [
"1 IVI Foundation, Valencia Spain.",
"3 Reproductive Medicine Research Group, IIS La Fe, Valencia, Spain.",
"5 IVI-RMA Rome, Rome, Italy."
],
"type": "Organization"
},
"familyName": "Pellicer",
"givenName": "Antonio",
"id": "sg:person.01125174440.05",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125174440.05"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1631/jzus.b1200181",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050882124",
"https://doi.org/10.1631/jzus.b1200181"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature04929",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009505802",
"https://doi.org/10.1038/nature04929"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10815-015-0595-y",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1036792268",
"https://doi.org/10.1007/s10815-015-0595-y"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bmt.1702695",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048075300",
"https://doi.org/10.1038/sj.bmt.1702695"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature02316",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031245923",
"https://doi.org/10.1038/nature02316"
],
"type": "CreativeWork"
}
],
"datePublished": "2019-02-21",
"datePublishedReg": "2019-02-21",
"description": "Diminished ovarian reserve (DOR) and primary ovarian insufficiency (POI) are primary factors leading to infertility. However, there is a lack of appropriate animal models of DOR usable for assessing new therapeutic strategies. In this study, we aimed to evaluate whether chemotherapy treatment in mice could reproduce features similar of that observed in women with DOR. Twenty-one Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) female mice were allocated to 3 groups (n = 7/group): control, single dose of vehicle (Dimethyl Sulfoxide [DMSO]); DOR, single reduced chemotherapy dose; and POI, single standard chemotherapy dose. After 21 days, mice underwent ovarian hyperstimulation and mating. Part of the animals were harvested to analyze ovarian reserve, ovulation and fertilization rates, and morphology, apoptosis, and vascularization of the ovarian stroma. The remaining mice underwent multiple matings to assess pregnancy rates and litter sizes. The DOR and POI mice showed an impaired estrous cyclicity and a decrease in ovarian mass, number of follicles, Metaphase II (MII) oocytes, and embryos as well as in ovarian stroma vascularization. Mice in both models showed also an increase in the percentage of morphologically abnormal follicles, stromal degeneration, and apoptosis. Similar to that observed in DOR and POI patients, these impairments were less severe in DOR than in POI mice. None of the POI females were able to achieve a pregnancy. Meanwhile, DOR females achieved several consecutive pregnancies, although litter size was decreased when compared to controls. In conclusion, a mouse model which displayed most of the ovarian characteristics and fertility outcomes of women with DOR has been established using a single dose of chemotherapy.",
"genre": "article",
"id": "sg:pub.10.1177/1933719119831784",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1112196",
"issn": [
"1933-7191",
"1933-7205"
],
"name": "Reproductive Sciences",
"publisher": "Springer Nature",
"type": "Periodical"
}
],
"keywords": [
"primary ovarian insufficiency",
"POI mice",
"ovarian reserve",
"chemotherapy dose",
"single dose",
"mouse model",
"number of follicles",
"appropriate animal models",
"nonobese diabetic/",
"new therapeutic strategies",
"metaphase II oocytes",
"stromal degeneration",
"ovarian hyperstimulation",
"ovarian damage",
"ovarian masses",
"POI patients",
"ovarian stroma",
"consecutive pregnancies",
"chemotherapy treatment",
"abnormal follicles",
"female mice",
"pregnancy rate",
"estrous cyclicity",
"ovarian insufficiency",
"diabetic/",
"therapeutic strategies",
"preclinical assessment",
"new therapies",
"ovarian characteristics",
"animal models",
"fertility outcomes",
"litter size",
"mice",
"dose",
"pregnancy",
"fertilization rate",
"follicles",
"women",
"vascularization",
"DOR",
"apoptosis",
"females",
"hyperstimulation",
"chemotherapy",
"patients",
"infertility",
"therapy",
"insufficiency",
"ovulation",
"degeneration",
"stroma",
"impairment",
"outcomes",
"treatment",
"control",
"days",
"animals",
"oocytes",
"rate",
"conclusion",
"group",
"percentage",
"damage",
"assessment",
"factors",
"decrease",
"study",
"primary factor",
"increase",
"lack",
"embryos",
"reserves",
"cyclicity",
"mating",
"mass",
"strategies",
"model",
"number",
"size",
"features",
"characteristics",
"part",
"tool",
"morphology",
"vehicles",
"multiple mating"
],
"name": "Diminished Ovarian Reserve Chemotherapy-Induced Mouse Model: A Tool for the Preclinical Assessment of New Therapies for Ovarian Damage.",
"pagination": "1933719119831784",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1112291919"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1177/1933719119831784"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"30791852"
]
}
],
"sameAs": [
"https://doi.org/10.1177/1933719119831784",
"https://app.dimensions.ai/details/publication/pub.1112291919"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:36",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_819.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1177/1933719119831784"
}
]
Download the RDF metadata as:Â json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1177/1933719119831784'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1177/1933719119831784'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1177/1933719119831784'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1177/1933719119831784'
This table displays all metadata directly associated to this object as RDF triples.
198 TRIPLES
22 PREDICATES
116 URIs
102 LITERALS
5 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1177/1933719119831784 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1112 |
3 | ″ | ″ | anzsrc-for:1114 |
4 | ″ | schema:author | N298e0ba3928346da97dc3a7dcaba824a |
5 | ″ | schema:citation | sg:pub.10.1007/s10815-015-0595-y |
6 | ″ | ″ | sg:pub.10.1038/nature02316 |
7 | ″ | ″ | sg:pub.10.1038/nature04929 |
8 | ″ | ″ | sg:pub.10.1038/sj.bmt.1702695 |
9 | ″ | ″ | sg:pub.10.1631/jzus.b1200181 |
10 | ″ | schema:datePublished | 2019-02-21 |
11 | ″ | schema:datePublishedReg | 2019-02-21 |
12 | ″ | schema:description | Diminished ovarian reserve (DOR) and primary ovarian insufficiency (POI) are primary factors leading to infertility. However, there is a lack of appropriate animal models of DOR usable for assessing new therapeutic strategies. In this study, we aimed to evaluate whether chemotherapy treatment in mice could reproduce features similar of that observed in women with DOR. Twenty-one Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) female mice were allocated to 3 groups (n = 7/group): control, single dose of vehicle (Dimethyl Sulfoxide [DMSO]); DOR, single reduced chemotherapy dose; and POI, single standard chemotherapy dose. After 21 days, mice underwent ovarian hyperstimulation and mating. Part of the animals were harvested to analyze ovarian reserve, ovulation and fertilization rates, and morphology, apoptosis, and vascularization of the ovarian stroma. The remaining mice underwent multiple matings to assess pregnancy rates and litter sizes. The DOR and POI mice showed an impaired estrous cyclicity and a decrease in ovarian mass, number of follicles, Metaphase II (MII) oocytes, and embryos as well as in ovarian stroma vascularization. Mice in both models showed also an increase in the percentage of morphologically abnormal follicles, stromal degeneration, and apoptosis. Similar to that observed in DOR and POI patients, these impairments were less severe in DOR than in POI mice. None of the POI females were able to achieve a pregnancy. Meanwhile, DOR females achieved several consecutive pregnancies, although litter size was decreased when compared to controls. In conclusion, a mouse model which displayed most of the ovarian characteristics and fertility outcomes of women with DOR has been established using a single dose of chemotherapy. |
13 | ″ | schema:genre | article |
14 | ″ | schema:inLanguage | en |
15 | ″ | schema:isAccessibleForFree | false |
16 | ″ | schema:isPartOf | sg:journal.1112196 |
17 | ″ | schema:keywords | DOR |
18 | ″ | ″ | POI mice |
19 | ″ | ″ | POI patients |
20 | ″ | ″ | abnormal follicles |
21 | ″ | ″ | animal models |
22 | ″ | ″ | animals |
23 | ″ | ″ | apoptosis |
24 | ″ | ″ | appropriate animal models |
25 | ″ | ″ | assessment |
26 | ″ | ″ | characteristics |
27 | ″ | ″ | chemotherapy |
28 | ″ | ″ | chemotherapy dose |
29 | ″ | ″ | chemotherapy treatment |
30 | ″ | ″ | conclusion |
31 | ″ | ″ | consecutive pregnancies |
32 | ″ | ″ | control |
33 | ″ | ″ | cyclicity |
34 | ″ | ″ | damage |
35 | ″ | ″ | days |
36 | ″ | ″ | decrease |
37 | ″ | ″ | degeneration |
38 | ″ | ″ | diabetic/ |
39 | ″ | ″ | dose |
40 | ″ | ″ | embryos |
41 | ″ | ″ | estrous cyclicity |
42 | ″ | ″ | factors |
43 | ″ | ″ | features |
44 | ″ | ″ | female mice |
45 | ″ | ″ | females |
46 | ″ | ″ | fertility outcomes |
47 | ″ | ″ | fertilization rate |
48 | ″ | ″ | follicles |
49 | ″ | ″ | group |
50 | ″ | ″ | hyperstimulation |
51 | ″ | ″ | impairment |
52 | ″ | ″ | increase |
53 | ″ | ″ | infertility |
54 | ″ | ″ | insufficiency |
55 | ″ | ″ | lack |
56 | ″ | ″ | litter size |
57 | ″ | ″ | mass |
58 | ″ | ″ | mating |
59 | ″ | ″ | metaphase II oocytes |
60 | ″ | ″ | mice |
61 | ″ | ″ | model |
62 | ″ | ″ | morphology |
63 | ″ | ″ | mouse model |
64 | ″ | ″ | multiple mating |
65 | ″ | ″ | new therapeutic strategies |
66 | ″ | ″ | new therapies |
67 | ″ | ″ | nonobese diabetic/ |
68 | ″ | ″ | number |
69 | ″ | ″ | number of follicles |
70 | ″ | ″ | oocytes |
71 | ″ | ″ | outcomes |
72 | ″ | ″ | ovarian characteristics |
73 | ″ | ″ | ovarian damage |
74 | ″ | ″ | ovarian hyperstimulation |
75 | ″ | ″ | ovarian insufficiency |
76 | ″ | ″ | ovarian masses |
77 | ″ | ″ | ovarian reserve |
78 | ″ | ″ | ovarian stroma |
79 | ″ | ″ | ovulation |
80 | ″ | ″ | part |
81 | ″ | ″ | patients |
82 | ″ | ″ | percentage |
83 | ″ | ″ | preclinical assessment |
84 | ″ | ″ | pregnancy |
85 | ″ | ″ | pregnancy rate |
86 | ″ | ″ | primary factor |
87 | ″ | ″ | primary ovarian insufficiency |
88 | ″ | ″ | rate |
89 | ″ | ″ | reserves |
90 | ″ | ″ | single dose |
91 | ″ | ″ | size |
92 | ″ | ″ | strategies |
93 | ″ | ″ | stroma |
94 | ″ | ″ | stromal degeneration |
95 | ″ | ″ | study |
96 | ″ | ″ | therapeutic strategies |
97 | ″ | ″ | therapy |
98 | ″ | ″ | tool |
99 | ″ | ″ | treatment |
100 | ″ | ″ | vascularization |
101 | ″ | ″ | vehicles |
102 | ″ | ″ | women |
103 | ″ | schema:name | Diminished Ovarian Reserve Chemotherapy-Induced Mouse Model: A Tool for the Preclinical Assessment of New Therapies for Ovarian Damage. |
104 | ″ | schema:pagination | 1933719119831784 |
105 | ″ | schema:productId | N4e09e0a735a348e9b2f5286682ae9c3e |
106 | ″ | ″ | N51375b0d58474b34b2c04be60809adb2 |
107 | ″ | ″ | Nb9922d757b394fef87619d52a27738c8 |
108 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1112291919 |
109 | ″ | ″ | https://doi.org/10.1177/1933719119831784 |
110 | ″ | schema:sdDatePublished | 2022-05-20T07:36 |
111 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
112 | ″ | schema:sdPublisher | N8188808e15744c759bb4cbd5acea82e8 |
113 | ″ | schema:url | https://doi.org/10.1177/1933719119831784 |
114 | ″ | sgo:license | sg:explorer/license/ |
115 | ″ | sgo:sdDataset | articles |
116 | ″ | rdf:type | schema:ScholarlyArticle |
117 | N298e0ba3928346da97dc3a7dcaba824a | rdf:first | sg:person.011724070757.34 |
118 | ″ | rdf:rest | Nb3b0e59f801c433ea68c026bc19d0d7a |
119 | N36b299d11e674a9583a845eeebebda91 | rdf:first | sg:person.01125174440.05 |
120 | ″ | rdf:rest | rdf:nil |
121 | N4e09e0a735a348e9b2f5286682ae9c3e | schema:name | pubmed_id |
122 | ″ | schema:value | 30791852 |
123 | ″ | rdf:type | schema:PropertyValue |
124 | N51375b0d58474b34b2c04be60809adb2 | schema:name | dimensions_id |
125 | ″ | schema:value | pub.1112291919 |
126 | ″ | rdf:type | schema:PropertyValue |
127 | N8188808e15744c759bb4cbd5acea82e8 | schema:name | Springer Nature - SN SciGraph project |
128 | ″ | rdf:type | schema:Organization |
129 | Nb3b0e59f801c433ea68c026bc19d0d7a | rdf:first | sg:person.010363147373.02 |
130 | ″ | rdf:rest | Nc748752437b44f0a9b100860c711d35f |
131 | Nb9922d757b394fef87619d52a27738c8 | schema:name | doi |
132 | ″ | schema:value | 10.1177/1933719119831784 |
133 | ″ | rdf:type | schema:PropertyValue |
134 | Nc748752437b44f0a9b100860c711d35f | rdf:first | sg:person.0725244145.42 |
135 | ″ | rdf:rest | N36b299d11e674a9583a845eeebebda91 |
136 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
137 | ″ | schema:name | Medical and Health Sciences |
138 | ″ | rdf:type | schema:DefinedTerm |
139 | anzsrc-for:1112 | schema:inDefinedTermSet | anzsrc-for: |
140 | ″ | schema:name | Oncology and Carcinogenesis |
141 | ″ | rdf:type | schema:DefinedTerm |
142 | anzsrc-for:1114 | schema:inDefinedTermSet | anzsrc-for: |
143 | ″ | schema:name | Paediatrics and Reproductive Medicine |
144 | ″ | rdf:type | schema:DefinedTerm |
145 | sg:journal.1112196 | schema:issn | 1933-7191 |
146 | ″ | ″ | 1933-7205 |
147 | ″ | schema:name | Reproductive Sciences |
148 | ″ | schema:publisher | Springer Nature |
149 | ″ | rdf:type | schema:Periodical |
150 | sg:person.010363147373.02 | schema:affiliation | grid-institutes:grid.5338.d |
151 | ″ | schema:familyName | Marchante |
152 | ″ | schema:givenName | Maria |
153 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010363147373.02 |
154 | ″ | rdf:type | schema:Person |
155 | sg:person.01125174440.05 | schema:affiliation | grid-institutes:None |
156 | ″ | schema:familyName | Pellicer |
157 | ″ | schema:givenName | Antonio |
158 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125174440.05 |
159 | ″ | rdf:type | schema:Person |
160 | sg:person.011724070757.34 | schema:affiliation | grid-institutes:grid.5338.d |
161 | ″ | schema:familyName | Buigues |
162 | ″ | schema:givenName | Anna |
163 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011724070757.34 |
164 | ″ | rdf:type | schema:Person |
165 | sg:person.0725244145.42 | schema:affiliation | grid-institutes:grid.419275.c |
166 | ″ | schema:familyName | Herraiz |
167 | ″ | schema:givenName | Sonia |
168 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0725244145.42 |
169 | ″ | rdf:type | schema:Person |
170 | sg:pub.10.1007/s10815-015-0595-y | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1036792268 |
171 | ″ | ″ | https://doi.org/10.1007/s10815-015-0595-y |
172 | ″ | rdf:type | schema:CreativeWork |
173 | sg:pub.10.1038/nature02316 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1031245923 |
174 | ″ | ″ | https://doi.org/10.1038/nature02316 |
175 | ″ | rdf:type | schema:CreativeWork |
176 | sg:pub.10.1038/nature04929 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1009505802 |
177 | ″ | ″ | https://doi.org/10.1038/nature04929 |
178 | ″ | rdf:type | schema:CreativeWork |
179 | sg:pub.10.1038/sj.bmt.1702695 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1048075300 |
180 | ″ | ″ | https://doi.org/10.1038/sj.bmt.1702695 |
181 | ″ | rdf:type | schema:CreativeWork |
182 | sg:pub.10.1631/jzus.b1200181 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1050882124 |
183 | ″ | ″ | https://doi.org/10.1631/jzus.b1200181 |
184 | ″ | rdf:type | schema:CreativeWork |
185 | grid-institutes:None | schema:alternateName | 5 IVI-RMA Rome, Rome, Italy. |
186 | ″ | schema:name | 1 IVI Foundation, Valencia Spain. |
187 | ″ | ″ | 3 Reproductive Medicine Research Group, IIS La Fe, Valencia, Spain. |
188 | ″ | ″ | 5 IVI-RMA Rome, Rome, Italy. |
189 | ″ | rdf:type | schema:Organization |
190 | grid-institutes:grid.419275.c | schema:alternateName | 4 IVI-RMA Valencia, Valencia, Spain. |
191 | ″ | schema:name | 1 IVI Foundation, Valencia Spain. |
192 | ″ | ″ | 3 Reproductive Medicine Research Group, IIS La Fe, Valencia, Spain. |
193 | ″ | ″ | 4 IVI-RMA Valencia, Valencia, Spain. |
194 | ″ | rdf:type | schema:Organization |
195 | grid-institutes:grid.5338.d | schema:alternateName | 2 Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, Valencia University, Valencia, Spain. |
196 | ″ | schema:name | 1 IVI Foundation, Valencia Spain. |
197 | ″ | ″ | 2 Department of Pediatrics, Obstetrics and Gynecology, School of Medicine, Valencia University, Valencia, Spain. |
198 | ″ | rdf:type | schema:Organization |